Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine,cisplatin|DRUG: Gemcitabine, Paclitaxel
Sponsor: Fudan University
Collaborators: 307 Hospital of PLA|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences|Sun Yat-sen University|Tianjin Medical University Cancer Institute and Hospital|Zhejiang Cancer Hospital|Changhai Hospital